Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Buy
52
CI Quote, Financials, Valuation and Earnings
Last price:
$273.78
Seasonality move
:
6.6%
Day range:
$273.29 - $275.94
52-week range:
$239.51 - $350.00
Dividend yield:
2.21%
P/E ratio:
12.08x
P/S ratio:
0.28x
P/B ratio:
1.75x
Volume:
1.4M
Avg. volume:
1.9M
1-year change:
-2.8%
Market cap:
$73.1B
Revenue:
$244.4B
EPS (TTM):
$22.67
Analysts' Opinion
-
Consensus RatingThe Cigna Group has received a consensus rating of Buy. The company's average rating is a Buy based on 15 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $324.92, The Cigna Group has an estimated upside of 17.9% from its current price of $273.75.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $270.00 representing 100% downside risk from its current price of $273.75.
Fair Value
-
According to the consensus of 19 analysts, The Cigna Group has 17.9% upside to fair value with a price target of $324.92 per share.
CI vs. S&P 500
-
Over the past 5 trading days, The Cigna Group has underperformed the S&P 500 by -2.5% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
The Cigna Group does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
The Cigna Group has grown year-over-year revenues for 55 quarters straight. In the most recent quarter The Cigna Group reported revenues of $69.8B.
Earnings Growth
-
The Cigna Group has grown year-over-year earnings for 4 quarters straight. In the most recent quarter The Cigna Group reported earnings per share of $6.98.
Enterprise value:
107.9B
EV / Invested capital:
1.42x
Price / LTM sales:
0.28x
EV / EBIT:
13.53x
EV / Revenue:
0.40x
PEG ratio (5yr expected):
0.11x
EV / Free cash flow:
14.50x
Price / Operating cash flow:
10.00x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
4.36%
Net Income Margin (TTM):
2.44%
Return On Equity:
15.87%
Return On Invested Capital:
8.94%
Operating Margin:
3.74%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $189.9B | $229.7B | $268.2B | $62.8B | $69.8B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | $8.4B | $6.9B | $9.6B | $1.7B | $2.6B | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $17.80 | $10.60 | $22.67 | $2.63 | $6.98 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $25.5B | $30.2B | $34.5B | $49.2B | $46.7B | |
| Total Assets | $149.2B | $139.4B | $144.7B | $153.1B | $153.7B | |
| Current Liabilities | $36.3B | $41.1B | $47.1B | $57.1B | $56.5B | |
| Total Liabilities | $101.7B | $94.3B | $99B | $110.8B | $111.7B | |
| Total Equity | $47.5B | $45.1B | $45.8B | $42.3B | $42B | |
| Total Debt | $34.9B | $32.1B | $31.1B | $32.8B | $30.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $12.4B | $6.6B | $8.7B | $46M | $3.4B | |
| Cash From Investing | -$5.4B | -$4.1B | -$4.3B | -$2B | -$4.4B | |
| Cash From Financing | -$5.7B | -$5.6B | -$5.6B | $439M | $2.7B | |
| Free Cash Flow | $10.9B | $5.2B | $7.4B | -$353M | $3.1B | |
CI
Sector
Market Cap
$73.1B
$28.4M
Price % of 52-Week High
78.22%
51.17%
Dividend Yield
2.21%
0%
Shareholder Yield
7.27%
-1.49%
1-Year Price Total Return
-0.48%
-16.67%
Beta (5-Year)
0.257
0.518
Dividend yield:
2.21%
Annualized payout:
$5.60
Payout ratio:
21.63%
Growth streak:
4 years
Technicals
8-day SMA
Sell
Level
$274.63
200-day SMA
Sell
Level
$301.38
Bollinger Bands (100)
Sell
Level
269.3 - 302.12
Chaikin Money Flow
Buy
Level
600.2M
20-day SMA
Buy
Level
$272.19
Relative Strength Index (RSI14)
Buy
Level
50.58
ADX Line
Sell
Level
12.11
Williams %R
Sell
Level
-12.1642
50-day SMA
Sell
Level
$276.89
MACD (12, 26)
Sell
Level
-0.27
25-day Aroon Oscillator
Sell
Level
-36
On Balance Volume
Neutral
Level
591.1M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.4692)
Sell
CA Score
(Annual)
Level (-0.6225)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (0.195)
Buy
Piotroski F Score
(Annual)
Level (6)
Sell
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
The Cigna Group is a global health company, which engages in the provision of global health services. It operates through the following segments: Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate. The Evernorth Health Services segment partners with health plans, employers, governmental organizations, and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. The Cigna Healthcare segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. The Other Operations segment consists of the remainder of business operations, which includes certain ongoing businesses and exited businesses. The Corporate segment refers to net interest expense, certain litigation matters, expense associated with frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs, and eliminations for products and services sold between segments. The company was founded in 1792 and is headquartered in Bloomfield, CT.
Stock Forecast FAQ
In the current month, CI has received 15 Buy ratings 4 Hold ratings, and 0 Sell ratings. The CI average analyst price target in the past 3 months is $324.92.
-
Where Will The Cigna Group Stock Be In 1 Year?
According to analysts, the consensus estimate is that The Cigna Group share price will rise to $324.92 per share over the next 12 months.
-
What Do Analysts Say About The Cigna Group?
Analysts are divided on their view about The Cigna Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that The Cigna Group is a Sell and believe this share price will drop from its current level to $270.00.
-
What Is The Cigna Group's Price Target?
The price target for The Cigna Group over the next 1-year time period is forecast to be $324.92 according to 19 Wall Street analysts, 15 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is CI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for The Cigna Group is a Buy. 15 of 19 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CI?
You can purchase shares of The Cigna Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase The Cigna Group shares.
-
What Is The The Cigna Group Share Price Today?
The Cigna Group was last trading at $273.78 per share. This represents the most recent stock quote for The Cigna Group. Yesterday, The Cigna Group closed at $273.75 per share.
-
How To Buy The Cigna Group Stock Online?
In order to purchase The Cigna Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get CI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CI
Sector
P/E ratio
12.08x
23.89x
PEG ratio
0.11x
-0.01x
P/B ratio
1.75x
1.81x
Price / LTM sales
0.28x
1.58x
Growth Metrics
CI
Sector
Revenue growth
11.15%
4.62%
Earnings growth
165.88%
10.7%
Revenue (5-year growth)
9.71%
6.5%
Earnings forecast
$7.64
-$0.21
Profitability
CI
Sector
Profitability FY 2024
--
$3.6M
Return on invested capital
8.94%
-31.84%
Return on assets
4.36%
-27.96%
Return on equity
15.87%
-37.63%
Earnings Date
Last Earnings Date
Oct
30
Next Earnings Date
Feb
5
Estimated Next Earnings Date
Jan
29
Balance Sheet
CI
Sector
Total cash
$5B
$26.4M
Short term investments
$665M
$25.7M
Total assets
$151.5B
$76.9M
Long term debt
$30.9B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Buy
60
ZBIO alert for Dec 23
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
Buy
54
UNF alert for Dec 23
UniFirst Corp. [UNF] is up 0.77% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
